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ABSTRACT
A pentacyclic triterpene, named salvibuchanic acid (1), together with five known compounds, were
isolated from the roots of Salvia buchananii Hedge (Lamiaceae). The structural characterization of
all compounds was performed by spectroscopic analyses, including 1D and 2D NMR, and HR-ESI-
MS experiments. The lupane triterpene (1) and hyptadienic acid (2) were  investigated for their
potential cytotoxic activity on Jurkat,  HeLa, and MCF7 cell  lines.  Both compounds showed an
interesting  antiproliferative  activity  with  similar  potency  in  all  cell  lines.  By  means  of  flow
cytometric studies, hyptadienic acid (2) induced in HeLa cells a S cell cycle block, while 1 elicited
both cytostatic and cytotoxic responses.
KEYWORDS: Salvia buchananii; pentacyclic triterpenes; salvibuchanic acid; phenolic derivatives;
cytotoxic activity.
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1. Introduction
Salvia  is an important genus of the Lamiaceae family (formerly Labiatae). Over 900 species are
widely distributed in different regions around the world such as the Mediterranean area, Central
Asia,  Africa,  and  America.  Secondary  metabolites  produced  by  Salvia plants  include
monoterpenoids, diterpenoids, having mainly an abietane or clerodane skeleton, sesquiterpenoids,
triterpenoids, flavonoids, and polyphenols (Wu et al. 2012). Aerial parts and roots of Salvia genus
have been used in traditional medicine for thousand years in the treatment of different diseases.
Diterpenoids  and  phenolic  derivatives  isolated  from  different  species  showed  antioxidant,
anticoagulant,  cytoprotective,  antihypertensive,  anti-fibrotic,  anti-ischemia-reperfusion  injury,
antiviral and antitumor activities (Li et al. 2013).
Salvia buchananii Hedge is a herbaceous perennial shrub, up to 50 cm high, with purple flowers
and ovate-lanceolate to spathulate leaves. In a previous chemical study of S. buchananii aerial parts
clerodane diterpenes, ursolic and oleanolic acids were isolated from the surface dichloromethane
extract (Bisio et al. 2015). Moreover, the dichloromethane extract of S. buchananii fresh aerial parts
was also investigated for its antioxidant (Giamperi et al. 2012) and antibacterial activities (Bisio et
al. 2015).  In the course of our investigation on Algerian  Salvia species (Kabouche & Kabouche
2008; Lakhal et al. 2014), herein, we report the isolation and the structure characterization of one
triterpene, named salvibuchanic acid (1) from S. buchananii roots (Figure 1), along with other five
known natural  compounds.  Besides,  salvibuchanic acid  (1) and hyptadienic  acid (2)  have been
evaluated  for  their  cytotoxic  activities  in  Jurkat,  HeLa,  and  MCF7  cancer  cell  lines.  Both
compounds showed an interesting antiproliferative activity  with similar potency in all cell lines.
Further studies revealed that  2 induced in HeLa cells a S cell cycle block, while  1 elicited both
cytostatic and cytotoxic responses.
2. Results and discussion
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Chloroform and chloroform-methanol extracts  of  S.buchananii roots,  were  fractionated by  flash
column chromatography followed by RP-HPLC, leading to the isolation of  one triterpene (1) and
five known compounds, namely hyptadienic acid (2) (Rao et al., 1990; Wang et al. 2009), maslinic
acid (Savona et al. 1983), caffeic acid methyl ester, caffeic acid (Saleem et al. 2004), and nepetoidin
B (Nakanishi et al. 1990). The structures of all compounds were determined by combination of
NMR and MS analyses and comparison of data with those reported in the literature.
Compound 1 was isolated as a white powder. The molecular formula was established to be C30H48O4
by  13C NMR and HR-ESI-MS analyses (m/z 495.3442 [M+Na]+,  calcd.  495.3450). The negative
ESI-MS  spectrum  showed  an  adduct  ion  peak at  m/z 517  [M+HCOO]−,  whereas  in  the  MS2
spectrum a prominent fragment at m/z 499 [M+HCOO−18]− was observed, due to the loss of a water
molecule. The neutral loss of CO2  from the parent ion (m/z at 473 [M+HCOO−44]
−) indicated the
presence of one carboxyl moiety. The 13C NMR spectrum of 1 (Table S1) exhibited thirty signals,
which were assigned to one carbonyl group (δ 180.7), 1,1-disubstituted double bond (δ 109.0 and
151.8),  one  hemiacetal  group  (δ  94.5),  and  one  hydroxymethylene  (δ  71.6).  These  evidences
suggested the presence of a pentacyclic triterpene, belonging to the lupane series (Yook et al. 2002).
The 1H NMR spectrum of 1 (Table S1) confirmed the presence of a structure with six methyl groups
(δ 0.83, 0.95, 1.03, 1.05, 1.07, and 1.72), two olefinic protons at δ 4.71 and 4.90 (each 1H, br s).
Assignments of all  1H and  13C NMR chemical  shifts  were ascertained on the basis of  1D total
correlation spectroscopy (TOCSY), double-quantum filtred correlated spectroscopy (DQF-COSY),
heteronuclear single quantum coherence (HSQC) analyses. The 1D-TOCSY experiments suggested
the sequences:  C-1—C-2,  C-5—C-7, C-9—C-13, C-15—C-16,  and C-18—C-22 confirming the
presence  of  a  pentacyclic  system.  A  combination  of  HSQC  and  heteronuclear  multiple  bond
coherence (HMBC) data  led to establish the location of all substituents.  The HMBC  correlations
between the proton signals at δ 1.72 (H-30) and the carbon resonances at δ 48.0 (C- 19), 109.0 (C-
29),  and 151.8 (C-20);  δ  4.71 (H-29b) and 4.90 (H-29a) and δ 48.0 (C-19) and 151.8 (C-20),
confirmed the position of the C-20/C-29 double bond. The signal at δ 1.65 (H-18) correlated with
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carbon resonances at δ 48.0 (C-19), 57.4 (C-17), 151.8 (C-20), and 180.7 (C-28), while the proton
signal at δ 1.46 (H-22b) showed long range correlations between signals at δ 31.1 (C-21), 50.0 (C-
18),  and  57.4  (C-17),  confirming  the  location  of  carboxylic  group  at  C-17.  The  connectivities
between the proton signal at δ 2.14 (H-1a) and the carbon resonances at δ 41.7 (C-10), 48.4 (C-9),
61.4 (C-5) and 94.5 (C-2) substantiated the presence of hemiacetal group at C-2. The location of the
epoxy group at C-2/C-3 position was verified by HMBC correlations between signal at δ 3.90 (H-
3a) and the resonances at δ 39.7 (C-4), 61.4 (C-5), and 94.5 (C-2) (Figure S1). This compound was
previously reported in a Chinese patent and its stereochemistry at C-2 was reported as β (Gao et al.
2015).  However,  the  presence  of  the  hemiacetal  function  at  C-2  leads  to  an  α/β equilibrium.
Compound  1 was therefore  identified as  2,3-seco-2,3-epoxy-2-hydroxylup-20(29)-en-28-oic acid
and was named salvibuchanic acid.
In  the  frame  of  our  project  aimed  to  study  the  cytotoxic  activity  of  plant  terpenes,  the
antiproliferative activity of compounds 1 and 2 was evaluated in Jurkat, HeLa, and MCF7 cancer
cell lines. Cells were exposed to increased concentrations of 1 and 2 and cell viability was evaluated
at 48 h by MTT assay. Half maximal inhibitory concentration (IC50) values, obtained from dose-
response curves, are shown in Table 1. Compounds 1 and 2 showed an interesting antiproliferative
activity  with similar potency in all cell lines. In particular, HeLa resulted slight more susceptible
than Jurkat and MCF7 cells.  Cells were also treated to different concentrations of etoposide, as a
positive  control,  and  showed three  different  IC50 values  (Table  1).  Jurkat  cells  were  most  the
sensitive to the action of etoposide, followed by HeLa cells, whereas the MCF7 cells were the most
resistant. Furthermore, the cytotoxic potential of compounds 1 and 2 was evaluated in PBMC from
healthy donors, chosen as the normal counterpart of leukemia- derived Jurkat cell line. Compounds
1 and 2 did not cause any significant reduction of the number of freshly isolated non-proliferating
PBMC, at least in the range of cytotoxic doses in leukemia cells. The mechanism(s) underlying
their  antiproliferative  effect  was  further  investigated  in  HeLa  cells.  To  investigate  whether
compounds 1 and 2 reduced cells number by affecting cell cycle progression and/or by inducing cell
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death, HeLa cells were exposed for 48 h at concentrations close to their IC50 value, 30 and 50 µM
for compound 1 and 15 and 35 µM for compound 2, respectively; DNA content was evaluated by
flow cytometry analysis of propidium iodide (PI) stained nuclei. As shown in Figure 2A, compound
1 caused an increase of cell population in S phase. Moreover, an increase of cells with sub G0/G1
DNA content was observed, thus indicating the onset of apoptotic events. Compound 2 induced a
robust and dose-dependent S block without any significant increase of hypodiploid cells (Figure
2B).
In conclusion, salvibuchanic acid (1), a lupane triterpene having an unusual seven-membered lactol
ring in the A-ring is reported. The cytotoxic activity of salvibuchanic acid (1) and hyptadienic acid
(2) was evaluated: these triterpenes may be worthy of further research as potential anticancer drugs.
3. Experimental
Salvibuchanic  acid (1).  White  powder  [α]D =  +17 (c  0.1,  MeOH);  HR-ESI-MS:  m/z 495.3442
[M+Na]+ (calcd for  C30H48O4Na, 495.3450), 477.34 [M+Na-18]
+; ESI-MS:  m/z 517 [M+HCOO]−,
499 [M+HCOO-18]+, 473 [M+HCOO-44]−;  1H NMR (600 MHz, CD3OD) δ: 0.83 (3H, s, Me-23),
0.88 (1H, dd, J = 11.8, 6.0 Hz, H-5), 0.95 (3H, s, Me-24), 1.03 (3H, s, Me-27), 1.05 (3H, s, Me-25),
1.07  (3H,  s,  Me-26),  1.21  (1H,  m,  H-15b),  1.30  (1H,  dd,  J =  9.5,  4.2  Hz,  H-9),  1.37  (1H,
overlapped,  H-1b),  1.38  (1H,  overlapped,  H-21b),  1.40  (1H,  overlapped,  H-16b),  1.44  (1H,
overlapped,  H-7b),  1.46  (1H,  overlapped,  H-22b),  1.54  (1H,  overlapped,  H-15a),  1.55  (1H,
overlapped,  H-6b),  1.57  (1H,  overlapped,  H-6a),  1.62  (1H,  overlapped, H-12b),  1.64  (1H,
overlapped, H-12a), 1.65 (1H, br d, J = 11.5 Hz, H-18), 1.72 (1H, s, Me-30), 1.93 (1H, m, H-22a),
1.98 (1H, overlapped, H-21a), 2.14 (1H, dd, J = 13.0, 1.5 Hz, H-1a), 2.28 (1H, m, H-7a), 2.42 (1H,
dd, J = 11.4, 4.0 Hz, H-13), 3.04 (1H, d, J = 11.8 Hz, H-3b), 3.09 (1H, ddd, J = 16.0, 11.5, 4.6 Hz,
H-19), 3.90 (1H, d, J = 11.8 Hz, H-3a), 4.71 (1H, br s, H-29b), 4.90 (1H, br s, H-29a), 5.00 (1H, dd,
J = 11.0, 5.5 Hz, H-2); 13C NMR (600 MHz, CD3OD) δ: 14.6 (C-27), 15.0 (C-25), 17.0 (C-26), 19.1
(C-30), 20.7 (C-24), 22.0 (C-11), 23.0 (C-6), 26.8 (C-12), 27.6 (C-23), 30.5 (C-15), 31.0 (C-16),
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31.1 (C-21), 33.1 (C-7), 38.0 (C-22), 39.6 (C-13), 39.7 (C-4 and C-8), 41.7 (C-10), 43.4 (C-14),
45.8 (C-1), 48.0 (C-19), 48.4 (C-9), 50.0 (C-18), 57.4 (C-17), 61.4 (C-5), 71.6 (C-3), 94.5 (C-2),
109.0 (C-29), 151.8 (C-20), 180.7 (C-28).
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Table 1. IC50 (µM) values of compounds 1 and 2 against three cancer cell lines
a.
Compounds Jurkat HeLa MCF7
1 38 ± 0.9 40 ± 2.1 70 ± 3.1
2 30 ± 13 25 ± 1.5 55 ± 2.3
Etoposide 2.5 ± 0.8 4 ± 1.1 12 ± 2.2
a Mean values ± SD from three experiments done in quadruplicate.
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Figure 1. Structures of compounds 1 and 2.
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Figure 2. Effect of compounds 1 and 2 on proliferation of HeLa cells. Flow cytometric evaluation
of DNA content in HeLa cells exposed for 48 h to  1 and 2 or vehicle alone (controls). (A) HeLa
cells exposed to 30 and 50 µM compound 1; (B) HeLa cells exposed to 15 and 35 µM compound 2.
Data are presented as increase⁄decrease in percentages of treated cells with a specific DNA content,
in respect to control values (control cells, subG0⁄G1, ≤2%; G0⁄G1, 53 ± 1.8%; S, 37 ± 2.1%; G2⁄M, 12
± 0.9%). All results are mean values ± SD from at least three experiments performed in duplicate
(*p< 0.05, **p< 0.001).
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